Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Feb 28;12(1):124-127.
doi: 10.21037/hbsn-22-625. Epub 2023 Jan 6.

Ascites and complications: getting to the root of the trouble

Mattias Mandorfer  1 , Benedikt Simbrunner  1
Affiliations
Editorial

Ascites and complications: getting to the root of the trouble

Mattias Mandorfer et al. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: Cirrhosis; albumin; portal hypertension; transjugular intrahepatic portosystemic shunt (TIPS).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-22-625/coif). MM served as a speaker and/or consultant and/or advisory board member for AbbVie, Collective Acumen, Gilead, and Takeda, and W. L. Gore & Associates and received travel support from AbbVie and Gilead. BS received travel support from AbbVie and Gilead. The authors have no other conflicts of interest to declare.

Figures

Figure 1
Figure 1
Pathophysiological cascade of ascites development and currently available therapeutic interventions. NSBB, non-selective betablocker; TIPS, transjugular intrahepatic portosystemic shunt; RAAS, renin-angiotensin-aldosterone system.
See this image and copyright information in PMC

Comment on

References

    1. Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1014-48. 10.1002/hep.31884 - DOI - PubMed
    1. Mandorfer M, Simbrunner B. Prevention of First Decompensation in Advanced Chronic Liver Disease. Clin Liver Dis 2021;25:291-310. 10.1016/j.cld.2021.01.003 - DOI - PubMed
    1. European Association for the Study of the Liver . Electronic address: easloffice@easloffice; . EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018;69:406-60. 10.1016/j.jhep.2018.03.024 - DOI - PubMed
    1. de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII - Renewing consensus in portal hypertension. J Hepatol 2022;76:959-74. 10.1016/j.jhep.2021.12.022 - DOI - PMC - PubMed
    1. Villanueva C, Albillos A, Genescà J, et al. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2019;393:1597-608. 10.1016/S0140-6736(18)31875-0 - DOI - PubMed